Hjem › Psoriasis › Texas › San Antonio
Psoriasis kliniske forsøg i San Antonio, TX
5 studier for Psoriasis søger deltagere på steder i og omkring San Antonio (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
RekruttererFase 2
- Rheumatology Associates of South Texas, San Antonio
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
RekruttererFase 3
- Vanda Investigational Site, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RekruttererFase 4
- Texas Dermatology and Laser Specialists, San Antonio
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
RekruttererFase 3
- Texas Dermatology and Laser Specialists, San Antonio
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
RekruttererFase 2
- Study Center, San Antonio
Psoriasis forsøg i andre byer
- Trenton, NJ7 studier
- Newton, MA6 studier
- Cleveland, OH6 studier
- Philadelphia, PA5 studier
- New York City, NY5 studier
- Fremont, CA5 studier
- Huntington Beach, CA4 studier
- Birmingham, AL4 studier
- San Diego, CA3 studier
- Rochester, NY3 studier
- Columbus, OH3 studier
- Sacramento, CA3 studier
Andre studier i San Antonio
- Ikke-småcellet lungecancer59 studier
- Colorektal kræft46 studier
- Brystkræft46 studier
- Metastatisk cancer44 studier
- Kræft (alle typer)41 studier
- Overvægt40 studier
- Type 2-diabetes37 studier
- Overvægt34 studier
- Ægstockræft31 studier
- Bugspytkirtelkræft31 studier
- Prostatakræft28 studier
- Livmoderslimhindekræft27 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.